MetaCap

AgomAb Therapeutics NV SEC Filings

NASDAQ: AGMBHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

9.08-0.14 (-1.52%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

AgomAb Therapeutics NV filing overview

This page lists 26 recent SEC filings by AgomAb Therapeutics NV (AGMB), including 10 6-K, 6 4, 5 SCHEDULE 13G, 1 20-F. Form 10-K is the audited annual report, 10-Q the quarterly report, 8-K covers material events, and Form 4 reports insider transactions. All documents link directly to SEC EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

AGMB SEC filings

AgomAb Therapeutics NV SEC filings
FiledFormDescriptionDocument
Oct 9, 20264Statement of changes in beneficial ownershipView on EDGAR
Oct 7, 20264Statement of changes in beneficial ownershipView on EDGAR
Oct 7, 20264Statement of changes in beneficial ownershipView on EDGAR
Oct 7, 20264Statement of changes in beneficial ownershipView on EDGAR
Oct 1, 20266-KReport of foreign private issuerView on EDGAR
Sep 15, 20264OWNERSHIP DOCUMENTView on EDGAR
Sep 15, 20264OWNERSHIP DOCUMENTView on EDGAR
Sep 14, 20266-KReport of foreign private issuerView on EDGAR
Sep 11, 20266-KReport of foreign private issuerView on EDGAR
Aug 10, 20266-KReport of foreign private issuerView on EDGAR
Aug 6, 20266-KReport of foreign private issuerView on EDGAR
Jun 23, 20266-KReport of foreign private issuerView on EDGAR
May 27, 20266-KReport of foreign private issuerView on EDGAR
May 15, 2026SCHEDULE 13GBeneficial ownership report (passive)View on EDGAR
May 15, 2026SCHEDULE 13GBeneficial ownership report (passive)View on EDGAR
May 6, 2026SCHEDULE 13GBeneficial ownership report (passive)View on EDGAR
Apr 24, 20266-KReport of foreign private issuerView on EDGAR
Apr 23, 202620-FAnnual report (foreign private issuer)View on EDGAR
Apr 16, 2026SCHEDULE 13GBeneficial ownership report (passive)View on EDGAR
Mar 6, 2026SCHEDULE 13GBeneficial ownership report (passive)View on EDGAR
Mar 5, 20266-KReport of foreign private issuerView on EDGAR
Feb 17, 2026SCHEDULE 13DBeneficial ownership report (activist)View on EDGAR
Feb 9, 20266-KReport of foreign private issuerView on EDGAR
Feb 6, 2026424B4ProspectusView on EDGAR
Jan 29, 2026F-1/ARegistration statement (foreign issuer) (amendment)View on EDGAR
Jan 16, 2026F-1Registration statement (foreign issuer)View on EDGAR

Related